Distal super-enhancer drives aberrant CXCL13 expression in Cancer cells driving growth and p53 dysregulation via CXCR5-CXCL13 axis
Santosh Kumar Gothwal, Kyungjae Myung, Pieta K. Mattila, Jacqueline H. Barlow
This study identifies a distal super-enhancer near CCNG2 that drives aberrant CXCL13 expression in cancer cells, leading to growth promotion and p53 dysregulation via the CXCR5-CXCL13 axis.
Cancer Cell International · Oct 31, 2026Peer-reviewedCancer Biology